The landscape of drug discovery, particularly for complex neurodegenerative diseases like ALS (Amyotrophic Lateral Sclerosis), is undergoing rapid transformation with the advent of artificial intelligence. Louisiana is making significant strides in this arena with the inception of the Louisiana AI
Menstrual blood, often considered merely a byproduct of a natural biological process, is gaining attention as a potential source for health diagnostics. This innovative approach to using menstrual blood, rather than traditional venipuncture blood tests, opens new avenues for understanding and
In the evolving landscape of medical imaging, technological advancement holds immense potential in transforming global healthcare outcomes. Dr. Ge Wang stands at the forefront of this transformation, contributing significantly through his work in X-ray computed tomography (CT) and artificial
The realm of drug discovery has always been a complex, costly, and time-consuming endeavor, with high failure rates due to intrinsic complexities. Among the pivotal challenges is the need to meticulously screen thousands or even millions of molecules to identify one with the desired therapeutic
In Westbury, New York, an MRI machine claimed the life of Keith McAllister, a 61-year-old man, prompting a serious reevaluation of the safety protocols governing such powerful diagnostic tools. On July 16, an ordinary medical appointment took a tragic turn when McAllister, adorned with a 20-pound
In the quest to combat cancer, innovation sits at the heart of every breakthrough. The relentless pursuit of effective therapies has led scientists on a path filled with challenges and triumphs. As many grapple with diseases like intrahepatic cholangiocarcinoma, breast and bladder cancers,
In the realm of pharmaceutical research, decentralized clinical trials (DCTs) are emerging as a transformative force, promising to redefine how clinical studies are conducted. These trials address the traditional challenges that have long plagued clinical research, including limited participant
In 2025, scientists continue grappling with puzzles surrounding the γ-secretase enzyme. Known for its role in Alzheimer’s disease and cancer, understanding its function remains daunting—an elusive target in biomedical research. As artificial intelligence (AI) steps into the arena, could this
The field of cancer treatment is witnessing seismic shifts as MiNK Therapeutics, a clinical-stage biotechnology firm and subsidiary of Agenus Inc., introduces groundbreaking cell-based therapies focused on treating challenging cancers. With its pioneering work on invariant natural killer T (iNKT)
In the dynamic world of biopharma, few individuals possess as vast an understanding of technology and innovation in the field as Ivan Kairatov. With a solid background in research and development, Ivan offers invaluable insights into the recent advancements and decisions impacting the
